Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 3924917
[patent_doc_number] => 05876988
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-02
[patent_title] => 'Selection marker gene free recombinant strains: method for obtaining them and the use of these strains'
[patent_app_type] => 1
[patent_app_number] => 8/880557
[patent_app_country] => US
[patent_app_date] => 1997-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 59
[patent_figures_cnt] => 66
[patent_no_of_words] => 24693
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/876/05876988.pdf
[firstpage_image] =>[orig_patent_app_number] => 880557
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/880557 | Selection marker gene free recombinant strains: method for obtaining them and the use of these strains | Jun 22, 1997 | Issued |
Array
(
[id] => 4353674
[patent_doc_number] => 06200799
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-13
[patent_title] => 'Somatic gene therapy to suppress secondary cataract formation following eye surgery'
[patent_app_type] => 1
[patent_app_number] => 8/867902
[patent_app_country] => US
[patent_app_date] => 1997-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 7697
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/200/06200799.pdf
[firstpage_image] =>[orig_patent_app_number] => 867902
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/867902 | Somatic gene therapy to suppress secondary cataract formation following eye surgery | Jun 2, 1997 | Issued |
08/861323 | NOVEL ADENOVIRAL VECTOR FOR TRANSFERRING HUMAN GENES IN VIVO | May 20, 1997 | Abandoned |
Array
(
[id] => 3781532
[patent_doc_number] => 05821119
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-13
[patent_title] => 'Shuttle vectors for Escherichia coli and cyanobateria'
[patent_app_type] => 1
[patent_app_number] => 8/855483
[patent_app_country] => US
[patent_app_date] => 1997-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7189
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/821/05821119.pdf
[firstpage_image] =>[orig_patent_app_number] => 855483
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/855483 | Shuttle vectors for Escherichia coli and cyanobateria | May 12, 1997 | Issued |
Array
(
[id] => 4221249
[patent_doc_number] => 06010878
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-04
[patent_title] => 'Interleukin-1 .beta. converting enzyme like apoptotic protease-6'
[patent_app_type] => 1
[patent_app_number] => 8/852936
[patent_app_country] => US
[patent_app_date] => 1997-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 23443
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/010/06010878.pdf
[firstpage_image] =>[orig_patent_app_number] => 852936
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/852936 | Interleukin-1 .beta. converting enzyme like apoptotic protease-6 | May 7, 1997 | Issued |
08/852924 | GENE TRANSFER WITH ADENOVIRUSES HAVING MODIFIED FIBER PROTEINS | May 7, 1997 | Abandoned |
Array
(
[id] => 4212648
[patent_doc_number] => 06110672
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-29
[patent_title] => 'Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof'
[patent_app_type] => 1
[patent_app_number] => 8/836325
[patent_app_country] => US
[patent_app_date] => 1997-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 14
[patent_no_of_words] => 51359
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/110/06110672.pdf
[firstpage_image] =>[orig_patent_app_number] => 836325
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/836325 | Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof | May 1, 1997 | Issued |
Array
(
[id] => 6921764
[patent_doc_number] => 20010029249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-11
[patent_title] => 'ADENOVIRUS COMPRISING A GENE CODING FOR GLUTATHIONE PEROXIDASE'
[patent_app_type] => new
[patent_app_number] => 08/776786
[patent_app_country] => US
[patent_app_date] => 1997-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4283
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20010029249.pdf
[firstpage_image] =>[orig_patent_app_number] => 08776786
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/776786 | ADENOVIRUS COMPRISING A GENE CODING FOR GLUTATHIONE PEROXIDASE | Apr 30, 1997 | Abandoned |
08/850218 | RETINA-ASSOCIATED GENES | Apr 29, 1997 | Abandoned |
Array
(
[id] => 1585124
[patent_doc_number] => 06358732
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-19
[patent_title] => 'DNA for expression under control of a cell cycle-dependent promoter'
[patent_app_type] => B1
[patent_app_number] => 08/793110
[patent_app_country] => US
[patent_app_date] => 1997-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6254
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/358/06358732.pdf
[firstpage_image] =>[orig_patent_app_number] => 08793110
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/793110 | DNA for expression under control of a cell cycle-dependent promoter | Apr 24, 1997 | Issued |
Array
(
[id] => 4328232
[patent_doc_number] => 06312946
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-06
[patent_title] => 'Viable contaminant particle free adenoviruses, their prepartion and use'
[patent_app_type] => 1
[patent_app_number] => 8/817575
[patent_app_country] => US
[patent_app_date] => 1997-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 24
[patent_no_of_words] => 14215
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/312/06312946.pdf
[firstpage_image] =>[orig_patent_app_number] => 817575
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/817575 | Viable contaminant particle free adenoviruses, their prepartion and use | Apr 21, 1997 | Issued |
Array
(
[id] => 4288349
[patent_doc_number] => 06235497
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-22
[patent_title] => 'Recombinant expression of the rat vesicular acetylcholine transporter'
[patent_app_type] => 1
[patent_app_number] => 8/793044
[patent_app_country] => US
[patent_app_date] => 1997-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3805
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/235/06235497.pdf
[firstpage_image] =>[orig_patent_app_number] => 793044
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/793044 | Recombinant expression of the rat vesicular acetylcholine transporter | Apr 20, 1997 | Issued |
Array
(
[id] => 4118406
[patent_doc_number] => 06071892
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-06
[patent_title] => 'Tyrosyl tRNA synthetase polynucleotides'
[patent_app_type] => 1
[patent_app_number] => 8/844054
[patent_app_country] => US
[patent_app_date] => 1997-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12533
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/071/06071892.pdf
[firstpage_image] =>[orig_patent_app_number] => 844054
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/844054 | Tyrosyl tRNA synthetase polynucleotides | Apr 17, 1997 | Issued |
Array
(
[id] => 4352861
[patent_doc_number] => 06218185
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-17
[patent_title] => 'Piggybac transposon-based genetic transformation system for insects'
[patent_app_type] => 1
[patent_app_number] => 8/844274
[patent_app_country] => US
[patent_app_date] => 1997-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 64
[patent_no_of_words] => 11003
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/218/06218185.pdf
[firstpage_image] =>[orig_patent_app_number] => 844274
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/844274 | Piggybac transposon-based genetic transformation system for insects | Apr 17, 1997 | Issued |
08/843866 | HAIR FOLLICLE DNA DELIVERY SYSTEM | Apr 16, 1997 | Abandoned |
Array
(
[id] => 3963423
[patent_doc_number] => 05885777
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-23
[patent_title] => 'Cloning, expression and characterization of a novel form of phosphatidylinositol-3-kinase'
[patent_app_type] => 1
[patent_app_number] => 8/817090
[patent_app_country] => US
[patent_app_date] => 1997-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5054
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/885/05885777.pdf
[firstpage_image] =>[orig_patent_app_number] => 817090
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/817090 | Cloning, expression and characterization of a novel form of phosphatidylinositol-3-kinase | Apr 10, 1997 | Issued |
Array
(
[id] => 3770327
[patent_doc_number] => 05807681
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-15
[patent_title] => 'Human retinoblastoma-related (pRb2/p130) genomic DNA and methods for detecting mutations therein'
[patent_app_type] => 1
[patent_app_number] => 8/832883
[patent_app_country] => US
[patent_app_date] => 1997-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 16179
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/807/05807681.pdf
[firstpage_image] =>[orig_patent_app_number] => 832883
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/832883 | Human retinoblastoma-related (pRb2/p130) genomic DNA and methods for detecting mutations therein | Apr 3, 1997 | Issued |
08/809977 | ADENOVIRUS-DERIVED VIRAL VECTORS HAVING TWO THERAPEUTIC GENES: SUICIDE AND IMMUNOPOTENTIATING | Apr 1, 1997 | Abandoned |
Array
(
[id] => 4325012
[patent_doc_number] => 06319669
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-20
[patent_title] => 'Modified green fluorescent proteins'
[patent_app_type] => 1
[patent_app_number] => 8/727452
[patent_app_country] => US
[patent_app_date] => 1997-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 7454
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/319/06319669.pdf
[firstpage_image] =>[orig_patent_app_number] => 727452
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/727452 | Modified green fluorescent proteins | Mar 19, 1997 | Issued |
Array
(
[id] => 4062829
[patent_doc_number] => 06008022
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-28
[patent_title] => 'Human cytokine polypeptide'
[patent_app_type] => 1
[patent_app_number] => 8/820970
[patent_app_country] => US
[patent_app_date] => 1997-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20163
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/008/06008022.pdf
[firstpage_image] =>[orig_patent_app_number] => 820970
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/820970 | Human cytokine polypeptide | Mar 18, 1997 | Issued |